• Gamifying Eye Health, Heavy Investments, Acquisitions in Decentralized Trials, More

    Clinical Research News | Launch of the Decentralized Trials & Research Alliance, acquisitions focused on decentralized trials and remote administration, new wearables for remote monitoring, better training for nurses in clinical settings, and more.

    Jan 4, 2021

  • Top Stories of 2020: Real-World Data, Research Ethics, and Virtual Trials. And COVID-19

    Clinical Research News | This year clinicians everywhere have worked to understand COVID-19, but that wasn’t the only disease we were concerned about. Crucial research on cancer, rare diseases, and many other indications was put on hold while sponsors and CROs re-envisioned clinical trials virtually and worked to reassure participants that they were safe at sites.

    Dec 29, 2020

  • The Pandemic Has Proven a New Approach to Clinical Trials is Necessary

    Clinical Research News | The COVID-19 pandemic has accelerated the need for a new approach to how clinical trial teams work with patients. At the onslaught of the health crisis, restrictions, and heavy precautions on personal interactions brought clinical trials to a veritable standstill. This left the life sciences industry looking for alternative ways to maintain patient participation in clinical trials, primarily, as it relates to patient interaction and data collection.

    Dec 22, 2020

  • Follow the Money: Decentralized Trials, Stem Cell Research, Stroke Treatment

    Clinical Research News | Funding updates around the clinical research and clinical trials space including a Series C round to accelerate decentralized trials, a “digital health first” focused VC fund, more money for a healthcare ecosystem platform, an investment in prostate health at Mount Sinai, and an NIH grant for human placental stem cell research.

    Dec 21, 2020

  • Online Programs Piloted To Support ‘Long COVID’, Drive-Through and Live-In Trial Sites, AI Picks Drug Candidates: COVID-19 Updates

    Clinical Research News | COVID-19 deadlier than heart disease, cancer, and the flu, with in-hospital mortality rates 20.3% among inpatients. New data on baricitinib and remdesivir. Plus: NIH looks at SARS-CoV-2 infection in children, CDC uses Oracle’s EHR, Curebase launches drive-through clinical trial sites, and new vaccine trials launched.

    Dec 18, 2020